Synergistic combination of PEA & luteolin
to support healthy nervous and immune systems*
to support healthy nervous and immune systems*
What is PEA?
Palmitoylethanolamide (PEA) is a biologically active, endogenous lipid that is widely distributed throughout the body's tissues and is produced on demand. (Gabrielsson 2016) It was first isolated from egg yolks in 1957 as an anti-inflammatory component. It is found in nearly all animal tissues, human breast milk, and many foods. (Mirica's PEA has been isolated from palm kernels.) PEA has been studied extensively for its anti-inflammatory, neuroprotective and analgesic properties since the 1970's.* (Hesselink 2013)
PEA plays a key role in maintaining homeostasis by regulating many physiological reactions associated with pain and inflammation. Some chronic conditions can result in a hyper-immune response involving glial, microglial and mast cells. Excessive activation of these satellite, non-neuronal cells has been shown to maintain inflammation and result in neurodegeneration. PEA reduces excessive activation of these cells and decreases neuron loss.* (Raso 2014)
In a recent meta-analysis of PEA involving a total of 1484 chronic pain patients, those taking PEA reported pain levels an average of 2.7 points lower than the control groups after 60 days.* (Paladini 2016)
What is Luteolin?
Luteolin is a potent bioflavonoid with antioxidant and anti-inflammatory properties. Like PEA, luteolin has several mechanisms of action. It inhibits mast cells, as well as mast cell-dependent T cell activation.* (Theoharides 2018) In addition, it modulates microglial activation and inhibits pro-inflammatory cytokine production. (Dirscherl 2010) It also acts on GABA and opioid receptors in the spinal cord.* (Li 2015)
The Synergistic Combination of PEA & Luteolin
When combined, PEA and luteolin show enhanced anti-inflammatory, anti-oxidant and neuroprotective properties. Coadministration of PEA with luteolin has been shown to decrease mast cell activation significantly more than PEA or luteolin alone. This combination has been shown to reduce pro-inflammatory cytokines (TNF-alpha, IL-1 beta, IL-6) and chemokines (MIP-1 alpha, MIP-2) significantly more than PEA or luteolin alone. Additionally, PEA with luteolin was shown to reduce oxidative and nitrosative damage more effectively than PEA or luteolin alone.* (Impellizzeri 2018)
Side Effect Free
PEA occurs naturally in the body and in many foods. No side effects have been reported with its use, even at the highest doses. (Gabrielsson 2016)
The recommended daily dose of Mirica® is equivalent to the amount of luteolin found in one artichoke. At this dose luteolin is safe and no side effects have been reported.
Mirica® contains NO egg, dairy, gluten, wheat, peanut or soy and contains no binders, fillers or preservatives.
Mirica® is made in a cGMP registered, FDA registered facility in the USA and tested by an independent lab.
Made with pure Levagen® PEA
Dirscherl K, et al. "Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype." Journal of Neuroinflammation. 2010;7:3.
Gabrielsson L, Mattsson S, Fowler C. “Palmitoylethanolamide for the Treatment of Pain: Pharmacokinetics, Safety and Efficacy.” British Journal of Clinical Pharmacology 82.4(2016): 932–942.PMC. Web.18 Mar. 2018.
Hesselink,JK. “Evolution in Pharmacologic Thinking around the Natural Analgesic Palmitoylethanolamide: from Nonspecific Resistance to PPAR-Α Agonist and Effective Nutraceutical.” Journal of Pain Research, 2013,p. 625
Hesselink J, Kopsky D . “Palmitoylethanolamide, a Neutraceutical, in Nerve...” Journal of Pain Research 8 (2015): 729–734. PMC.Web.1 Dec. 2017.
Impellizzeri, D et al. “Palmitoylethanolamide and Luteolin Ameliorate Development of...” Arthritis Research & Therapy 15.6 (2013): R192.PMC.Web. 17 Mar. 2018.
Li, Ming et al. “Luteolin Improves the Impaired Nerve Functions in...” International Journal of Clinical and Experimental Pathology 8.9 (2015):10112–10120.
Paladini A, et al.“Palmitoylethanolamide, a Special Food for Medical Purposes, in the Treatment of..." Pain Physician. 2016 Feb;19(2):11-24.
Raso G etal. "Palmitoylethanolamide in CNS health and disease” Pharmacological Research Volume 86, Aug 2014, 32-41
* The statements on this website have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
The contents of this website are not medical advice and are intended for general knowledge and informational purposes only. You should consult a licensed health care professional before starting any supplement, dietary, or exercise program. Mirica is not intended for use by women who are pregnant or breastfeeding. Keep out of reach of children. Results may vary from person to person.
Customer reviews on this website are not the opinions of Young Nutraceuticals. Customer reviews should never replace a doctor's advice.
Levagen® is a registered trademark of Gencor, used under license by Young Nutraceuticals.